You have mites living in your hair follicles right now. Everyone does. Two species of microscopic parasites, Demodex folliculorum and Demodex brevis, set up camp on every human face and scalp, usually within the first few weeks of life. Under normal circumstances, they're harmless. Your immune system keeps them in check, they do their thing, and you never know they're there.
But when something shifts: hormones, immune suppression, chronic stress, excessive sebum production. Their numbers explode. And that's when they start destroying hair follicles from the inside out.
This is not some fringe theory. A 2025 cross-sectional study of 520 hair loss patients found that 66.15% tested positive for Demodex infestation, and there was a statistically significant, direct correlation between mite density and the severity of hair loss. That's not a coincidence. That's a pattern that should change how you approach differential diagnosis.
What Are Demodex Mites, Exactly?
Two species live on humans, and they do different things in different places. If you're going to take this seriously, and you should, you need to know what you're dealing with.
Their lifecycle is fast: 14 to 18 days from egg to adult. They go through five stages: egg, larva (6 legs), protonymph, nymph, and adult (8 legs). Eggs hatch in 3–4 days, and in about a week the larvae mature into adults ready to reproduce. They're nocturnal, coming to the surface at night to mate before burrowing back into the follicle.
When the population stays low, your immune system keeps everything stable. When it doesn't, that's when everything goes sideways.
The Study: 520 Patients, 66% Infested
Researchers in Tehran recruited 520 patients presenting with hair loss and sampled both the scalp and face for Demodex using light microscopy. Here's what they found:
The correlation is clear: the more mites they found, the worse the hair loss. That's not a casual association, but a direct, statistically significant correlation. And yet, how many practitioners are screening for this? Almost none.
How Demodex Actually Destroys Hair Follicles
The mechanism is specific and well-documented. A 2025 comprehensive review in Medicina breaks down the entire inflammatory cascade:
Step 1: Lipase-Driven Inflammation
Demodex mites secrete lipases, enzymes that break down fats. These lipases trigger inflammation directly around the sebaceous glands and the follicle lining. That's not a secondary response; that's the mite's own metabolic waste actively damaging tissue.
Step 2: Immune Cell Infiltration
The inflammation triggers your immune system. Neutrophils and macrophages flood the area around the follicle, creating a zone of chronic perifollicular inflammation. In isolation, that's your body trying to help. But sustained over weeks and months, that immune response starts doing more harm than the mites themselves.
Step 3: Die-Off Makes It Worse
When the mites die, conditions worsen before they improve. Dying mites release their chitinous exoskeletons and internal contents, including bacterial antigens from Bacillus oleronius, a bacterium that lives inside the mites. These antigens spike TLR-2 expression (a toll-like receptor involved in innate immunity), amplifying the inflammatory response even further.
Step 4: Fibrosis and Follicle Loss
If the infestation goes on long enough, the chronic inflammation leads to fibrosis (scar tissue forming around the follicle). Once fibrosis sets in, the follicle is gone. It's not miniaturized, it's not resting. It's permanently destroyed. That's the difference between catching this early and catching it late.
Demodicosis of the scalp typically presents as dryness, follicular scaling, superficial vesicles, and pustules. If you're seeing unexplained follicular pustules in a hair loss patient, especially with perifollicular redness and scaling that doesn't respond to standard treatments, consider Demodex. Get a skin scraping and look under the microscope. It takes five minutes.
Who's at Risk?
A 2025 systematic review in Infection (Springer) compiled the risk factors across the literature:
The research points to several populations where Demodex overgrowth is more likely: immunocompromised individuals (HIV, organ transplant recipients, patients on immunosuppressants), people with rosacea (Demodex is found in significantly higher densities in rosacea patients), those with excessive sebum production, patients using long-term topical corticosteroids (which suppress the local immune response and create a hospitable environment for mites), and individuals with androgenetic alopecia. In the latter case, Demodex-secreted lipases create a compounding effect on follicles already undergoing miniaturization.
The review also flagged something relevant for anyone in the transplant space: hair transplantation may create a favorable environment for demodicosis due to the tissue trauma involved. This matters for post-transplant patients who present with unexpected folliculitis.
Treatment: What the Evidence Actually Supports
Let me be clear. This is scope-of-practice territory. Prescribing medication is not in a trichologist's lane. But understanding what the research says about treatment helps you recognize what's working (or not working) when your clients are under a dermatologist's care, and it helps you make informed referrals.
Tea Tree Oil (Topical)
In vitro studies show that tea tree oil has the highest kill rate against Demodex compared to other topical options. A comparative study published in Clinical, Cosmetic and Investigational Dermatology found that tea tree oil and Thai herbal essential oils outperformed both ivermectin 1% and metronidazole 0.75% at killing Demodex in lab settings. This matters because it's an OTC option that clients can access without a prescription.
Concentration matters. The research used standardized preparations, not the diluted "tea tree shampoo" from a drugstore. For suspected Demodex cases, the evidence supports a 5% tea tree oil formulation applied to the affected area.
Topical Ivermectin (1%)
A case report in Dermatologica Sinica documented successful treatment of scalp demodicosis. Pruritus resolved and follicular papules cleared with no side effects. Topical ivermectin is prescription-only but increasingly used by dermatologists who are paying attention to Demodex.
Oral Ivermectin
A 2024 clinical study found that 75% of patients achieved clinical remission with oral ivermectin. Patients with lower Demodex densities had a median time to remission of 28 days; those with higher densities took about 56 days. It works, but recurrence rates remain a challenge across all treatment modalities.
Even after successful treatment, recurrence rates are high. The mites are part of our normal skin flora. You can't eradicate them entirely. The goal is to control the population, which means ongoing management rather than a one-and-done prescription. Clients need to understand this upfront.
What This Means for Trichologists
If two-thirds of hair loss patients in a clinical study tested positive for Demodex, and there's a direct link between mite density and hair loss severity, we need to be screening for this. Not on every client, but when someone presents with unexplained shedding, follicular inflammation, scaling, or hair loss that doesn't respond to the usual interventions, Demodex needs to be on the differential.
The Bottom Line
Two out of three hair loss patients in this study had Demodex. The mites secrete lipases that trigger inflammation, attract immune cells, cause fibrosis, and permanently destroy follicles. Tea tree oil shows the strongest topical kill rate in lab studies. Oral ivermectin achieves remission in 75% of cases. Yet most practitioners never check for it. If you're serious about differential diagnosis, this must become a standard screening.